​

Kronos Bio Ownership | Who Owns Kronos Bio?

OverviewForecastRevenueFinancialsChart

Kronos Bio Ownership Summary

Kronos Bio is owned by 24.27% insiders, and 75.73% retail investors. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.16% of its assets in Kronos Bio shares.

KRON Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKronos Bio-24.27%75.73%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251-97.92%1,663-99.99%-0.00%1-92.31%--100.00%
Mar 31, 202548-17.24%19,132,784-2.63%312.96%13-43.48%1550.00%
Dec 31, 202428-48.15%14,008,974-28.90%232.18%9-50.00%6-60.00%
Sep 30, 202453-5.36%19,689,996-4.63%322.71%17-19.05%157.14%
Jun 30, 202456-3.45%20,645,660-4.86%342.46%215.00%14-12.50%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.32M2.16%-
Vanguard Total Stock Mkt Idx Inv1.32M2.16%-
Vanguard Institutional Extnd Mkt Idx Tr559.54K0.92%-
Fidelity Extended Market Index234.08K0.38%-1.05K
Kennedy Micro Cap Opportunities148.07K0.25%11.66K
Bridgeway Ultra-Small Company Market118.93K0.20%-
iShares Micro-Cap ETF91.52K0.15%-
Forefront Tiresias Strategy86.58K0.14%2.19K
Bridgeway Ultra-Small Company77.47K0.13%-115.30K
Fidelity Total Market Index76.18K0.12%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 05, 2025KNOBELMAN DEBORAH President & Interim CEOSell$21.55K
Jun 27, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$478.84K
Jun 28, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$254.96K
Jun 11, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$814.57K
Jun 12, 2024BISCHOFBERGER NORBERT W PRESIDENT & CEOBuy$1.10M

Insider Transactions Trends

DateBuySell
2025 Q2-1
2024 Q4--
2024 Q25-
2024 Q1-6
2023 Q432

KRON Ownership FAQ

Who Owns Kronos Bio?

Kronos Bio shareholders are primarily institutional investors at 0.00%, followed by 24.27% insiders and 75.73% retail investors. The average institutional ownership in Kronos Bio's industry, Biotech Stocks , is 306.59%, which Kronos Bio falls below.

Does Blackrock own Kronos Bio?

BlackRock is not among the top 10 institutional shareholders of Kronos Bio.

Who is the top mutual fund holder of Kronos Bio shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Kronos Bio shares, with 2.16% of its total shares outstanding invested in 1.32M Kronos Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools